Omron Healthcare has completed the purchase of 18,459,288 shares of the target company, increasing the voting rights ratio to 95.88%.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6645","jir_company_name":"Omron Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-06-16","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/6645-20260616-01.pdf","jir_short_summary":"Omron Healthcare has completed the purchase of 18,459,288 shares of the target company, increasing the voting rights ratio to 95.88%.","jir_summary":"### Summary of the Buyback\nOmron Healthcare conducted a public purchase of the target company's shares from May 19 to June 15, 2026, acquiring all 17,567,455 shares tendered. The purchase price was 1,110 yen per share, resulting in an increase in the voting rights ratio from 14.64% to 95.88%, acquiring a majority of shares. As a result, the target company is expected to proceed with procedures for delisting from the stock exchange.\n\n### Future Policy and Outlook\nFollowing the completion of the buyback, Omron plans to acquire all shares of the target company and proceed with the delisting process. Specific procedures and schedules will be announced after consultations with the target company. This may lead to changes in the target company's business operations and stock liquidity.","jir_financial_highlights":"Shares Purchased: 18,459,288 shares (Voting rights ratio increased from 14.64% to 95.88%)\nPurchase Period: May 19, 2026 \u2013 June 15, 2026 (Period is 20 business days)\nPurchase Price: 1,110 yen\/share (No change)","jir_category":"","jir_hashtags":"#Omron, #IRRelated, #JapanStocks","jir_key_figures":"Shares Purchased: 18,459,288 shares\nVoting rights ratio: increased from 14.64% to 95.88%\nPurchase Price: 1,110 yen\/share","jir_meta_title":"\u3010Omron\u3011Share Buyback Completed\uff5cJune 2026","jir_meta_description":"Omron Healthcare has completed the share buyback, increasing the voting rights ratio to 95.88%. The delisting process will proceed shortly.","jir_og_title":"\u3010Omron\u3011Share Buyback Completed\uff5cJune 2026","jir_og_description":"Omron has completed the share buyback, significantly increasing the voting rights ratio. The delisting process will proceed accordingly.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7648,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"share_buyback","footnotes":""},"sector":[],"importance":[],"class_list":["post-65015","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n